| CXHL1500492 | SPH3127 | I-001 | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-06-03 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-05-04 | view |
| CXHL1500495 | SPH3127片 | I-001 | Tablet | Chemical Drugs(1.1) | New Drug Application | 2015-06-03 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-05-04 | view |
| CXHL1401770 | 醋酸艾司利卡西平 | eslicarbazepine acetate | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-05-12 | view |
| CXHL1401771 | 醋酸艾司利卡西平片 | eslicarbazepine acetate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-03 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-05-19 | view |
| CXSL1300111 | 重组抗CD20人源化单克隆抗体注射液 | Recombinant anti-CD20 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2014-05-12 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-08-23 | view |
| CXHL1501800 | 拉科酰胺 | lacosamide | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2015-09-25 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-08-23 | view |
| CXHL1600095 | SPH1188-11片 | SPH1188-11 | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-04-20 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXHL1600093 | SPH1188-11 | SPH1188-11 | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2016-04-20 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXHL1600094 | SPH1188-11片 | SPH1188-11 | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-04-20 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL1600070 | 注射用重组抗HER2人源化单克隆抗体组合物 | B-002 | Lyophilized | Biological Products(1) | New Drug Application | 2017-02-13 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2017-09-27 | view |
| CXHL1700225 | SPH3348 | SPH3348 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2017-11-24 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | In Review | 2017-11-22 | view |
| CXHL1700109 | 羟基雷公藤内酯醇片 | 5-Hydroxytriptolide | Tablet | Chemical Drugs(1) | New Drug Application | 2017-07-03 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Approval Completed-Pending Certificated | 2018-02-01 | view |
| CXHL1700108 | 羟基雷公藤内酯醇片 | 5-Hydroxytriptolide | Tablet | Chemical Drugs(1) | New Drug Application | 2017-07-03 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Approval Completed-Pending Certificated | 2018-02-01 | view |
| CXHL1700226 | SPH3348片 | SPH3348 | Tablet | Chemical Drugs(1) | New Drug Application | 2017-11-23 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2018-04-27 | view |
| CXHL1700227 | SPH3348片 | SPH3348 | Tablet | Chemical Drugs(1) | New Drug Application | 2017-11-23 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2018-04-27 | view |
| CXHL1700289 | SPH4480片 | SPH4480 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-06-28 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | In Review | 2018-06-26 | view |
| CXHL1700288 | SPH4480片 | SPH4480 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-06-28 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | In Review | 2018-06-26 | view |
| CXHL1700287 | SPH4480 | SPH4480 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-06-28 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | In Review | 2018-06-26 | view |
| CXHL2000137 | SPH4336片 | SPH4336 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-03-31 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | In Review | 2020-03-30 | view |
| CXHL2000138 | SPH4336片 | SPH4336 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-03-31 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | In Review | 2020-03-30 | view |
